1UK Prospective Diabetes Study Group.Quality of life in type 2 diabetes patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS37)[J].Diabetes Care,1999;22 (7):1125-36.
2Caroline S Blaum, Jeffry B Halter. Treatment of older adults with diabetes[ A]. In: C. Ronald Kahn, George L. King, Alan C. Moses, et al. Joslin' s Diabetes Mellitus[ M]. 14thed. Boston: Nesbitt Graphics, Inc, 2005. 737 - 763.
3Maxion-Bergemann S, Huppertz E, Jacobs LD, et al. Improved glycemic control with decreased hypoglycemia prevents long-term complications in type 2 diabetes patients : long-term simulation analysis using the " diabetes mellitus model" [ J]. Int J Clin Pharmacol Ther, 2005,43 (6):271 -281.
4Rosenstock J, Dailey G, Massi-Benedetti M, et al. Reduced hypoglycemia risk with insulin glargine: a meta-analysis comparing insulin glargine with human NPH insulin in type 2 diabetes[ J]. Diabetes Care, 2005,28 (4) : 950 - 955.
5Josse RG, Chiasson JL, Ryan EA, et al. Acarbose in the treatment of elderly patients with type 2 diabetes [ J]. Diabetes Res Clin Pract,2003,59( 1 ) : 37 -42.
7Skak K, Gotfredsen CF, Lundsgaard D, et al. Improved beta-cell survival and reduced insulitis in a type 1 diabetic rat model after treatment with a beta-cell-selective K (ATP)channel opener[J]. Diabetes, 2004,53 (4) : 1089-1095.
